 |
 |
||
| MSH News | |
||
 |
Events | ||
| Technical Seminars | |||
| Stories
|
|||
| Annual Report | |||
|
|||
 |
|||
| Download MSH Annual Report in PDF format or order a hardcopy from the eBookstore | |||
|
|
|
|
 |
 |
Home: News
Room: Events: World Conference on Lung Health—2004 MSH Presents at the World Conference on Lung Health October 28-November 1, 2004 Workshop
Oral Session
Poster Sessions
Friday 29 October 2004 - 13:00 – 17:00 Sponsors:
DESCRIPTION: Many NTPs continue to encounter problems in providing quality TB medicines to patients when they need them. While lack of financial resources may be one constraintfor procuring all TB medicines needed, NTPs also experience a host of other problems in pharmaceutical management.
The workshop will share common TB pharmaceutical management problems and how some TB programmes have solved them. Solutions presented during the workshop will include functional instruments for procuring a regular supply of quality TB pharmaceuticals and supplies, and for monitoring their storage, distribution and use within the system. TARGET AUDIENCE: Managers of TB and essential medicines programmes, drug policy makers and TB partners looking for mechanisms to support TB programmes OBJECTIVES:
SPEAKERS:
Sunday October 31 - 14:00-16:15 DESCRIPTION: The core symposium will address the growing attention given to incentives, enablers and performance-based financing within DOTS programmes. There is a wide range of approaches now being implemented that only sometimes involve piloting or evaluation. These include interventions aimed at increasing the motivation and capacity of TB patients, public and private providers, administrative authorities and community partners. Some of these approaches are controversial, as there is debate on whether they produce the expected actions by the beneficiaries, whether they represent a “slippery slope” towards market-driven interventions vs. public health objectives, and on their sustainability. At the same time, given the disabling environment in many settings, there is evidence that providing support for DOTS stakeholders to prioritize and fulfill their functions can be effective in improving DOTS results. TARGET AUDIENCE: Public health practitioners, researchers, policy makers and financial supporters. OBJECTIVES:
SECTION: Tuberculosis COORDINATOR: Peter Gondrie (The Netherlands) PRESENTATIONS:
14:00-14:20 14:25-14:45 14:50-15:10 15:15-15:35 15:40-16:00 16:00-16:15
Using a Laboratory Performance Improvement Program to enhance quality of services for TB and HIV/AIDS in Uganda Authors: C J F Mundy, S Johnson, P Mugyenyi, J Lagahid, R Viazon, P G Suarez, C M Whalen Address: Management Sciences for Health, Boston, USA. Joint Clinical Research Centre, Kampala, Uganda. INTRODUCTION: Efforts to improve laboratory performance frequently focus on training in laboratory techniques and providing equipment and consumables. Leadership and management strengthening has not been sufficient to create an institutional environment to leverage these investments and maintain technical quality. OBJECTIVES: To devise and pilot a programme to improve laboratory performance through strengthening the management systems and developing managers to lead. METHODS: Tools for strengthening leadership and management have been adapted to match the specific management components and challenges faced by laboratory networks in low-income countries with high prevalence of TB and TB/HIV and are being piloted and evaluated in Uganda. RESULTS: Preliminary results of a structured participatory self-assessment process to identify gaps in the laboratory management systems, and highlights of resulting management improvement plans will be presented. The framework for the Leadership Development Programme to address priority challenges affecting the efficiency and quality of services will also be presented. CONCLUSION: Improving leadership and management capacity of laboratory networks is essential for sustaining the quality and efficiency of services.
|
||
